Considerations for medical nutrition therapy management of the critically ill patient with hematological malignancies: A narrative review
- 26 April 2024
- journal article
- review article
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 39 (4) , 800-814
Abstract
Patients with hematological malignancies (HMs) are more frequently admitted now than in the past to the intensive care unit (ICU) due to more aggressive approaches in primary therapy of HMs and the need for critical care support. Pathophysiological alterations derived from HMs and the different hematological therapies, such as chemotherapy, negatively affect gastrointestinal (GI) function, metabolism, and nutrition status. Further, malnutrition strongly influences outcomes and tolerance of the different hematological therapies. In consequence, these critically ill patients frequently present with malnutrition and pathophysiological alterations that create challenges for the delivery of medical nutrition therapy (MNT) in the ICU. Frequent screening, gauging tolerance, and monitoring nutrition status are mandatory to provide individualized MNT and achieve nutrition objectives. The present review discusses how HM impact GI function and nutrition status, the importance of MNT in patients with HM, and specific considerations for guidance in providing adequate MNT to these patients when admitted to the ICU.Keywords
This publication has 122 references indexed in Scilit:
- The association between nutritional risk index and ICU outcomes across hematologic malignancy patients with acute respiratory failureAnnals of Hematology, 2022
- Malnutrition diagnosed by GLIM criteria better predicts long‐term outcomes for patients with non‐Hodgkin's lymphoma: A prospective multicenter cohort studyHematological Oncology, 2022
- Monitoring energy balance through clinical and serum biomarkers in patients with hematologic malignancies undergoing chemotherapyAnnals of Hematology, 2022
- NRS‐2002 and mNUTRIC score: Could we predict mortality of hematological malignancy patients in the ICU?Nutrition in Clinical Practice, 2021
- Toxicities of CD19 CAR‐T cell immunotherapyAmerican Journal of Hematology, 2019
- Clinical impact of sarcopenia and relevance of nutritional intake in patients before and after allogeneic hematopoietic stem cell transplantationJournal of Cancer Research and Clinical Oncology, 2017
- Outcome of critically ill patients with hematological malignanciesAnnals of Hematology, 2013
- Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantationAnnals of Hematology, 2012
- The effects of sedation on gastric emptying and intra-gastric meal distribution in critical illnessIntensive Care Medicine, 2007
- Intestinal motility disturbances in intensive care patients pathogenesis and clinical impactIntensive Care Medicine, 2006